Why the Proposed Rule Could Hinder the Home Health Public Market’s Strategic Visions
At the very beginning of this year, I wrote an HHCN+ Report on the home health public market and how it sets the pace for […]
At the very beginning of this year, I wrote an HHCN+ Report on the home health public market and how it sets the pace for […]
With the uncertainty surrounding the U.S. Centers for Medicare & Medicaid Services’ (CMS) new proposed payment rule, buyers and sellers in the M&A industry will […]
After multiple years of record-breaking M&A activity, home health consolidators are now starting to show an increased interest in organic growth. While the approach to […]
While the appetite for home health and home care M&A dealmaking remains strong, other health care subsectors are catching up. Coming off a record-breaking 2021 […]
Staffing is almost ubiquitously considered the toughest challenge in both home health and home care. A parallel issue that is often considered far less, however, […]
In terms of business, providers are slowly beginning to move away from the strict distinctions of home health, home care and hospice. “These are separate […]
Earlier this week, Axios reported that Humana Inc. (NYSE: HUM) is gearing up for a sale of Kindred at Home’s hospice business and seeking a […]
The ongoing public health emergency is sure to bring more staffing turmoil this year, along with additional regulatory and policy updates. The year ahead is […]
In the U.S. Centers for Medicare & Medicaid Services’ (CMS) proposed payment rule for 2022, the attention-grabber was the expansion of the Home Health Value-Based […]
Interest in acquisitions, mergers and joint venture arrangements continues to heat up in the home health space. But for every successful deal that’s closed, there’s […]
Special purpose acquisition companies (SPACs) have risen to immense popularity in the past 12 months. Many are becoming more intrigued by senior-focused investments as well. […]
Home health mergers and acquisitions got off to a slow start in 2020, then picked up considerably by year’s end. Home health insiders are now […]
On last week’s Q3 earnings call, Addus HomeCare Corporation (Nasdaq: ADUS) effectively declared that its “short pause” on M&A activity was officially over. On Wednesday, […]
M&A activity across home health, hospice and in-home care appeared to be “business as usual” at the start of 2020. COVID-19 froze the market in […]
Copyright © 2024 | WordPress Theme by MH Themes